NCT07557225
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Adnexal Diseases, +81 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Cholangiocarcinoma
Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
503 public trials
160 recruiting studies
Cholangiocarcinoma trial results
Recruiting
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NCT06735560
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
- Locations
-
- CHU de Nantes Nantes, France
- AP-HP - Site de Beaujon Paris, France
NCT06058663
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +8 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07570849
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- 180 Fenglin Road Shanghai, Shanghai Municipality, China
NCT06441747
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
- Monash Medical Centre Clayton, New South Wales, Australia
- Royal North Shore Hospital St Leonards, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
NCT07030140
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +13 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China
NCT07478523
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- CHU de Bordeaux Pessac, France
NCT07206355
- Conditions
- Adenocarcinoma, Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA), +19 more
- Locations
-
- University of Nottingham Nottingham, United Kingdom
NCT06723236
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +21 more
- Locations
-
- UCSF - Helen Diller Family Cancer Center San Francisco, California, United States
- Mass General Brigham Boston, Massachusetts, United States
- Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
- South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
NCT05655949
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +14 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States